The DiaPat® approach is based on the knowledge that diseases are reflected by the protein composition of body fluids. Proteins catalyze chemical reactions or protect the body against pathogens.
The DiaPat® test uses capillary electrophoresis coupled with mass spectrometry (CE-MS) to simultaneously analyse hundreds of proteins in a single analytical step, forming a diagnostic pattern. Patients at risk are identified by comparing their diagnostic pattern with the specific DiaPat® biomarker profile.
DiaPat® was clinically validated in blinded prospective studies and proved to be a reliable diagnostic tool.